-
Ventrica (Fremont, California) has come up with a technique that it believes could enable the automatic anastomosis (connection) of blood vessels, which may provide heart surgeons with an alternative to the conventional method of hand suturing.
-
CHICAGO, Illinois With the U.S. market introduction of the Cypher drug-eluting stent from the Cordis (Miami Lakes, Florida) unit of Johnson & Johnson (New Brunswick, New Jersey), interventional cardiology has entered a new era in which patient outcomes for revascularization procedures may, for the first time, become equivalent to surgery for many patients.
-
Higher costs to patients for prescription drugs and reductions in coverage by state health insurance are among changes to the public healthcare system identified by the German government late last month as it tries to come to grips with runaway costs in that sector.
-
Boston Scientific (BSX; Natick, Massachusetts) has made a second equity investment in and extended its exclusive option to acquire EndoTex Interventional Systems (Cupertino, California). In addition, Boston Sci has agreed to acquire EndoTex upon the achievement of certain regulatory milestones.
-
Boston Scientific (Natick, Massachusetts) said it has signed an agreement with MediGuide (Haifa, Israel), a privately held company, to develop and commercialize advanced imaging and navigational technologies for use in a broad range of less-invasive therapies.
-
Chances for a Medicare reform bill in this session of Congress among the myriad choices circulating offices on the Hill largely boil down to reaching an agreement on the type of reform and how far the legislation goes toward giving private insurers some entrance to the system.
-
-
Data from a murine model indicates the innate immune system is critical to control of Norovirus infection.
-
Human coronavirus OC43 accounted for 6% of respiratory illnesses studied in Normandy during a single season.
-
